MAPK13 controls structural remodeling and disease after epithelial injury
K. Wu, Y. Zhang, D. Mao, C. A. Iberg, H. Yin-Declue, K. Sun, S. P. Keeler, H. A. Wikfors, D. Young, J. Yantis, S. R. Austin, D. E. Byers, S. L. Brody, E. C. Crouch, M. J. Holtzman
This study identifies MAPK13 as a regulator of structural remodeling and disease after epithelial injury, showing its role in basal-epithelial stem cell hyperplasia and mucous metaplasia in both mouse and human models.
bioRxiv · May 31, 2024 · PreprintImmunology